vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.
PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $205.4M, roughly 1.8× COLLEGIUM PHARMACEUTICAL, INC). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs 8.3%, a 23.4% gap on every dollar of revenue. Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
COLL vs PB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $367.6M |
| Net Profit | $17.0M | $116.3M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 31.6% |
| Revenue YoY | 12.9% | — |
| Net Profit YoY | 35.3% | -10.7% |
| EPS (diluted) | $0.48 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $367.6M | ||
| Q4 25 | $205.4M | $275.0M | ||
| Q3 25 | $209.4M | $273.4M | ||
| Q2 25 | $188.0M | $267.7M | ||
| Q1 25 | $177.8M | $265.4M | ||
| Q4 24 | $181.9M | $267.8M | ||
| Q3 24 | $159.3M | $261.7M | ||
| Q2 24 | $145.3M | $258.8M |
| Q1 26 | — | $116.3M | ||
| Q4 25 | $17.0M | $139.9M | ||
| Q3 25 | $31.5M | $137.6M | ||
| Q2 25 | $12.0M | $135.2M | ||
| Q1 25 | $2.4M | $130.2M | ||
| Q4 24 | $12.5M | $130.1M | ||
| Q3 24 | $9.3M | $127.3M | ||
| Q2 24 | $19.6M | $111.6M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 65.1% | ||
| Q3 25 | 29.7% | 64.4% | ||
| Q2 25 | 18.7% | 64.3% | ||
| Q1 25 | 12.2% | 62.7% | ||
| Q4 24 | 20.9% | 62.0% | ||
| Q3 24 | 21.9% | 62.1% | ||
| Q2 24 | 32.7% | 55.2% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | 8.3% | 50.9% | ||
| Q3 25 | 15.0% | 50.3% | ||
| Q2 25 | 6.4% | 50.5% | ||
| Q1 25 | 1.4% | 49.1% | ||
| Q4 24 | 6.9% | 48.6% | ||
| Q3 24 | 5.9% | 48.6% | ||
| Q2 24 | 13.5% | 43.1% |
| Q1 26 | — | $1.16 | ||
| Q4 25 | $0.48 | $1.48 | ||
| Q3 25 | $0.84 | $1.45 | ||
| Q2 25 | $0.34 | $1.42 | ||
| Q1 25 | $0.07 | $1.37 | ||
| Q4 24 | $0.36 | $1.36 | ||
| Q3 24 | $0.27 | $1.34 | ||
| Q2 24 | $0.52 | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $8.2B |
| Total Assets | $1.7B | $43.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
| Q1 26 | — | $8.2B | ||
| Q4 25 | $301.7M | $7.6B | ||
| Q3 25 | $274.8M | $7.7B | ||
| Q2 25 | $232.2M | $7.6B | ||
| Q1 25 | $234.4M | $7.5B | ||
| Q4 24 | $228.8M | $7.4B | ||
| Q3 24 | $234.3M | $7.4B | ||
| Q2 24 | $216.6M | $7.3B |
| Q1 26 | — | $43.6B | ||
| Q4 25 | $1.7B | $38.5B | ||
| Q3 25 | $1.6B | $38.3B | ||
| Q2 25 | $1.6B | $38.4B | ||
| Q1 25 | $1.6B | $38.8B | ||
| Q4 24 | $1.7B | $39.6B | ||
| Q3 24 | $1.6B | $40.1B | ||
| Q2 24 | $1.1B | $39.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $78.3M | ||
| Q3 25 | $78.4M | $194.8M | ||
| Q2 25 | $72.4M | $98.2M | ||
| Q1 25 | $55.4M | $178.2M | ||
| Q4 24 | $84.6M | $-205.8M | ||
| Q3 24 | $-9.0M | $274.6M | ||
| Q2 24 | $67.4M | $216.5M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $68.5M | ||
| Q3 25 | $78.3M | $185.7M | ||
| Q2 25 | $72.4M | $91.8M | ||
| Q1 25 | $54.6M | $171.1M | ||
| Q4 24 | $84.1M | $-210.7M | ||
| Q3 24 | $-9.2M | $270.2M | ||
| Q2 24 | $67.1M | $211.8M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 24.9% | ||
| Q3 25 | 37.4% | 67.9% | ||
| Q2 25 | 38.5% | 34.3% | ||
| Q1 25 | 30.7% | 64.5% | ||
| Q4 24 | 46.2% | -78.7% | ||
| Q3 24 | -5.8% | 103.3% | ||
| Q2 24 | 46.2% | 81.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 3.6% | ||
| Q3 25 | 0.1% | 3.3% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.4% | 2.7% | ||
| Q4 24 | 0.3% | 1.8% | ||
| Q3 24 | 0.2% | 1.7% | ||
| Q2 24 | 0.2% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 0.56× | ||
| Q3 25 | 2.49× | 1.42× | ||
| Q2 25 | 6.05× | 0.73× | ||
| Q1 25 | 22.92× | 1.37× | ||
| Q4 24 | 6.75× | -1.58× | ||
| Q3 24 | -0.96× | 2.16× | ||
| Q2 24 | 3.44× | 1.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
